Skip to main content

Advertisement

Log in

Do breast quadrants explain racial disparities in breast cancer outcomes?

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Tumors of the inner quadrants of the breast are associated with poorer survival than those of the upper-outer quadrant. It is unknown whether racial differences in breast cancer outcomes are modified by breast quadrant, in addition to comparisons among Asian subgroups.

Methods

Using the Surveillance, Epidemiology, and End Results database, we analyzed data among women diagnosed with non-metastatic invasive breast cancer between 1990 and 2014. We performed Cox proportional hazards regression models to assess the associations of race with breast cancer-specific survival and overall survival, stratified by breast quadrants. The models were adjusted for age, year of the diagnosis, tumor size, grade, histological type, tumor laterality, lymph node, estrogen receptor, progesterone receptor, and treatments.

Results

Among 454,154 patients (73.0% White, 10.0% Black, 7.8% Asian/PI, and 9.2% Hispanic), 54.3% had tumors diagnosed in the upper-outer quadrant of the breast. Asian/PI women were more likely than White to have tumors diagnosed in the nipple/central portion of the breast and were less likely to have diagnosed in the upper-outer quadrant (P < 0.001), despite a similar distribution of breast quadrant between Black, Hispanic, and White women. Compared with White women, the multivariable-adjusted hazard ratios of breast cancer-specific mortality were 1.41 (95% CI 1.37–1.44) in Black women, 0.82 (95% CI 0.79–0.85) in Asian women, and 1.05 (95% CI 1.02–1.09) in Hispanic women. Among Asian subgroups, Japanese American women had a lower risk of breast cancer-specific mortality (HR = 0.68, 95% CI 0.62–0.74) compared with White women. Overall survival was similar to breast cancer-specific survival in each race group. The race-associated risks did not vary significantly by breast quadrants for breast cancer-specific mortality and all-cause mortality.

Conclusions

Differences in breast cancer survival by race could not be attributed to tumor locations. Understanding the cultural, biological, and lifestyle factors that vary between White, African American, and ethnic subgroups of Asian American women may help explain these survival differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets analyzed during the current study are available from the first author on reasonable request.

Abbreviations

BCS:

Breast-conserving surgery

BCSM:

Breast cancer-specific mortality

BCSS:

Breast cancer-specific survival

CI:

Confidence interval

ER:

Estrogen receptor

HR:

Hazard ratio

NOS:

Not otherwise specified

OS:

Overall survival

PI:

Pacific Islander

PR:

Progesterone receptor

SEER:

Surveillance, Epidemiology, and End Results

References

  1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin. 69:7–34

    Article  PubMed  Google Scholar 

  2. Smith RA, Andrews KS, Brooks D et al (2017) Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 67:100–121

    Article  PubMed  Google Scholar 

  3. DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 66:31–42

    Article  PubMed  Google Scholar 

  4. Lohrisch C, Jackson J, Jones A, Mates D, Olivotto IA (2000) Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828–2835

    Article  CAS  PubMed  Google Scholar 

  5. Zucali R, Mariani L, Marubini E et al (1998) Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363–1366

    Article  CAS  PubMed  Google Scholar 

  6. Gaffney DK, Tsodikov A, Wiggins CL (2003) Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467–472

    Article  PubMed  Google Scholar 

  7. Siotos C, McColl M, Psoter K et al (2018) Tumor site and breast cancer prognosis. Clinical Breast Cancer 18:e1045–e1052

    Article  PubMed  Google Scholar 

  8. Perkins CI, Hotes J, Kohler BA, Howe HL (2004) Association between breast cancer laterality and tumor location, United States, 1994–1998. Cancer Causes Control: CCC 15:637–645

    Article  PubMed  Google Scholar 

  9. Lee AH (2005) Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses. Breast (Edinburgh, Scotland) 14:151–152

    Article  Google Scholar 

  10. Bao J, Yu KD, Jiang YZ, Shao ZM, Di GH (2014) The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study. PLoS ONE 9:e94815

    Article  PubMed  PubMed Central  Google Scholar 

  11. Colleoni M, Zahrieh D, Gelber RD et al (2005) Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 23:1390–1400

    Article  PubMed  Google Scholar 

  12. Sohn VY, Arthurs ZM, Sebesta JA, Brown TA (2008) Primary tumor location impacts breast cancer survival. Am J Surg 195:641–644

    Article  PubMed  Google Scholar 

  13. Giess CS, Keating DM, Osborne MP, Ng YY, Rosenblatt R (1998) Retroareolar breast carcinoma: clinical, imaging, and histopathologic features. Radiology 207:669–673

    Article  CAS  PubMed  Google Scholar 

  14. Nicholson BT, Harvey JA, Cohen MA (2009) Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics 29:509–523

    Article  PubMed  Google Scholar 

  15. Turner-Warwick RT (1959) The lymphatics of the breast. Br J Surg 46:574–582

    Article  CAS  PubMed  Google Scholar 

  16. Savaridas SL, Spratt JD, Cox J (2015) Incidence and potential significance of internal mammary lymphadenopathy on computed tomography in patients with a diagnosis of primary breast cancer. Breast Cancer: Basic Clin Res 9:59–65

    Google Scholar 

  17. Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM (2018) Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study. Cancer Manage Res 10:1133–1141

    Article  Google Scholar 

  18. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165–173

    Article  CAS  PubMed  Google Scholar 

  19. National Cancer Institute. Surveillance, Epidemiology, and End Results program. SEER incidence data, 1973-2015.

  20. National Cancer Institute. Surveillance, Epidemiology, and End Results program. Quadrants of the Breast.

  21. Park JJ, Humble S, Sommers BD, Colditz GA, Epstein AM, Koh HK (2018) Health Insurance for Asian Americans, Native Hawaiians, and Pacific Islanders Under the Affordable Care Act. JAMA Intern Med 178:1128–1129

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gomez SL, Von Behren J, McKinley M et al (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164:139–147

    Article  PubMed  PubMed Central  Google Scholar 

  23. VanderWeele TJ (2009) On the distinction between interaction and effect modification. Epidemiology (Cambridge, Mass.). 20:863–871

    Article  Google Scholar 

  24. Shahar KH, Buchholz TA, Delpassand E et al (2005) Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103:1323–1329

    Article  PubMed  Google Scholar 

  25. Warner ET, Tamimi RM, Hughes ME et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254–2261

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sakamoto G, Sugano H (1991) Pathology of breast cancer: present and prospect in Japan. Breast Cancer Res Treat 18(Suppl 1):S81–S83

    Article  PubMed  Google Scholar 

  27. Stemmermann GN (1991) The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res Treat 18(Suppl 1):S67–S72

    Article  PubMed  Google Scholar 

  28. Shoemaker ML, White MC, Wu M, Weir HK, Romieu I (2018) Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. Breast Cancer Res Treat 169:595–606

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lamb EP, Pritchard FE, Nouer SS et al (2018) Understanding disparities in breast cancer care in Memphis. Tennessee Am Surg 84:620–627

    PubMed  Google Scholar 

  30. Parkes A, Warneke CL, Clifton K et al (2018) Prognostic factors in patients with metastatic breast cancer with bone-only metastases. Oncologist 23:1282–1288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. DeSantis CE, Siegel RL, Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 66:290–308

    Article  PubMed  Google Scholar 

  32. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728

    Article  PubMed  Google Scholar 

  33. Akinyemiju T, Moore JX, Altekruse SF (2015) Breast cancer survival in African-American women by hormone receptor subtypes. Breast Cancer Res Treat 153:211–218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349

    Article  PubMed  Google Scholar 

  35. Kwan ML, John EM, Caan BJ et al (2014) Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol 179:95–111

    Article  PubMed  Google Scholar 

  36. Nahleh Z, Otoukesh S, Mirshahidi HR et al (2018) Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med 7:2710–2717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e997–e1002

    Article  PubMed  Google Scholar 

  38. Haji-Jama S, Gorey KM, Luginaah IN, Balagurusamy MK, Hamm C (2013) Health insurance mediation of the Mexican American non-Hispanic white disparity on early breast cancer diagnosis. SpringerPlus 2:285

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist 18:986–993

    Article  PubMed  PubMed Central  Google Scholar 

  40. Stevenson JKR, Cheung MC, Earle CC et al (2018) Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer System. Cancer 124:1473–1482

    Article  PubMed  Google Scholar 

  41. Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control: CCC 17:771–781

    Article  PubMed  Google Scholar 

  42. Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ (1998) Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis 8:218–227

    CAS  PubMed  Google Scholar 

  43. Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME (2016) The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: toward strengthening the critical relationship. Am J Surg Pathol 40:e94–e102

    Article  PubMed  PubMed Central  Google Scholar 

  44. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M (2013) The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5:3–29

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Dr. Han was supported by foundations from Barnes-Jewish Hospital and Breast Cancer Research Foundation (award ID: BCRF-17-028). Dr. Colditz is supported by the Breast Cancer Research Foundation. Drs. Moore, Langston, Fuzzell, Khan, and Lewis were supported by the Washington University School of Medicine, Public Health Sciences Division Postdoctoral Training in Cancer Prevention and Control, and a training grant from the National Cancer Institute of the National Institutes of Health under award number T32CA190194. YL is supported by an American Cancer Society—Denim Days Research Scholar Grant (RSG-18-116-01-CPHPS) and the National Cancer Institute (R01CA215418). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

As this study is based on a publicly available database without identifying patient information, informed consent was not needed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 338 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, Y., Moore, J.X., Langston, M. et al. Do breast quadrants explain racial disparities in breast cancer outcomes?. Cancer Causes Control 30, 1171–1182 (2019). https://doi.org/10.1007/s10552-019-01222-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-019-01222-x

Keywords

Navigation